david fortin
Université de Sherbrooke
Sherbrooke, Canada
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
Université de Sherbrooke
Sherbrooke, Canada
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Associate Editor
Cancer Immunity and Immunotherapy
University of Catania
Catania, Italy
Associate Editor
Gynecological Oncology
Levine Cancer Institute
Charlotte, United States
Associate Editor
Cancer Immunity and Immunotherapy
Department of Biomedical Sciences, University of Padova
Padova, Italy
Associate Editor
Cancer Immunity and Immunotherapy
IRCCS Ca 'Granda Foundation Maggiore Policlinico Hospital
Milan, Italy
Associate Editor
Hematologic Malignancies
Institute of Biomedical Sciences, Center for Health Science, Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Associate Editor
Pharmacology of Anti-Cancer Drugs
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy
Associate Editor
Gynecological Oncology
AUSL / IRCCS Institute of Neurological Sciences
Bologna, Italy
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
Agostino Gemelli University Polyclinic (IRCCS)
Rome, Italy
Associate Editor
Surgical Oncology
University of Messina
Messina, Italy
Associate Editor
Cancer Immunity and Immunotherapy
University of Florence
Florence, Italy
Associate Editor
Genitourinary Oncology
Centro di Riferimento Oncologico di Aviano (CRO)
Aviano, Italy
Associate Editor
Molecular and Cellular Oncology
Technion Israel Institute of Technology
Haifa, Israel
Associate Editor
Cancer Imaging and Image-directed Interventions
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Associate Editor
Molecular and Cellular Oncology
Department of Radiation Oncology, University Hospital Erlangen
Erlangen, Germany
Associate Editor
Cancer Immunity and Immunotherapy